pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,879 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 138 phase 2 completion · 64 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion138
  • phase 1 completion64
phase 1 initiation
39
  • phase 2 initiation35
  • phase 1 2 completion29
  • phase 0 trial completion22
  • therapy area
    • Infectious Disease3

    Date TBD

    50
    ›COMPLETEDphase readoutNCT06254144: Neuroimaging Study for Decoding Emotional States and Identifying Neural Circuits to Disengage From Negative Thinking

    Sponsor: Laureate Institute for Brain Research, Inc.. Phase: . Conditions: Depressive Disorder, Major

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07432009: Orthopedic Procedures and Postoperative Delirium in Older Adults in the Czech Republic

    Sponsor: Tomas Bata Hospital, Czech Republic. Phase: . Conditions: Frailty, Cognitive Impairment, Older Adults, Hip Arthroplasty, Postoperative Delirium

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00003809: Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

    Sponsor: Eastern Cooperative Oncology Group. Phase: PHASE3. Conditions: Head and Neck Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07544199: Transdiagnostic Dimensional Profiling of Neurodevelopmental Disorders

    Sponsor: IRCCS Eugenio Medea. Phase: . Conditions: Neurodevelopmental Disorder (Diagnosis)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04334031: Deployment o the Multidisciplinary Prospective Cohort Imminent

    Sponsor: University Hospital, Lille. Phase: NA. Conditions: Chronic Inflammatory Disease, Angioedema, Severe Asthma, Lupus, Atopic Dermatitis, Psoriatic Arthritis, Multiple Sclerosis, Systemic Sclerosis, Behçet Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT02577731: Hematopoietic Stem Cell Dysfunction in the Elderly After Severe Injury

    Sponsor: University of Florida. Phase: NA. Conditions: Trauma Injury

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04903002: Evaluating the Efficacy of Intranasal Oxytocin on Chronic Pain

    Sponsor: Memorial University of Newfoundland. Phase: PHASE2. Conditions: Chronic Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06915337: Magnet Anastomosis in Patients Undergoing Gastric Surgery

    Sponsor: GI Windows, Inc.. Phase: NA. Conditions: Gastric Anastomosis (Site)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03439137: Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan

    Sponsor: Tanabe Pharma Corporation. Phase: PHASE3. Conditions: Anemia; Hemodialysis Dependent Chronic Kidney Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05642572: Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

    Sponsor: SWOG Cancer Research Network. Phase: PHASE2. Conditions: Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06110195: Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer

    Sponsor: University of Chicago. Phase: PHASE1. Conditions: Head and Neck Cancer, Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07338539: BIO-SHORT: Biologically Guided Short-Course Hypofractionated RT for Poor-Prognosis GBM

    Sponsor: Tata Memorial Centre. Phase: PHASE2. Conditions: Glioma

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT06701175: Knee Arthroscopy for Pain Control

    Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Knee Arthroscopy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06333457: Presence and Relapse Rates in Patients With Alcohol Use Disorder Using Virtual Reality

    Sponsor: Charite University, Berlin, Germany. Phase: . Conditions: Alcohol Dependence

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03980457: Effects of Exoskeleton-Assisted Gait Training on Functional Rehabilitation Outcomes in Patients With Stroke

    Sponsor: University of Oklahoma. Phase: NA. Conditions: Stroke, Weakness of Extremities as Sequela of Stroke

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07395401: Evaluation of Zinc Oxide Eugenol and Iodoform-Calcium Hydroxide as Filling Materials in Primary Molar Root Canals Prepared by Rotary and Manual Files

    Sponsor: October University for Modern Sciences and Arts. Phase: NA. Conditions: Carious Primary Molars Indicated for Pulpectomy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07465081: Ultra-processed Food Consumption and Behavioral Disorder and Cognitive Function

    Sponsor: China Medical University Hospital. Phase: NA. Conditions: ADD/ADHD

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07392281: Efficacy and Mechanisms of Macitentan for Non-Coronary Obstructive Angina

    Sponsor: China-Japan Friendship Hospital. Phase: EARLY_PHASE1. Conditions: Non-Coronary Obstructive Angina

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06395181: Whole Food Plant-based Diet Effect on Obstructive Sleep Apnea

    Sponsor: Mayo Clinic. Phase: NA. Conditions: Obstructive Sleep Apnea, Daytime Sleepiness

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03190681: Motivation and Methylphenidate

    Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: EARLY_PHASE1. Conditions: Motivation, Apathy, Impulsive Behavior

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06589128: Efficacy of Investigator Product for the Amelioration of Digital Eye Strain in Children

    Sponsor: Universiti Sains Malaysia. Phase: NA. Conditions: Digital Eye Strain (DES)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06091228: The Additional Effect of Tongue Scraping on Halitosis Parameters in Initial Periodontal Therapy

    Sponsor: Universitaire Ziekenhuizen KU Leuven. Phase: NA. Conditions: Periodontitis, Halitosis, Tongue Condition

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05025800: ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Aggressive B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 3 Follicular Lymphoma, Ann Arbor Stage III Marginal Zone Lymphoma, Ann Arbor Stage IV Grade 1 Follicular Lymphoma, Ann Arbor Stage IV Grade 2 Follicular Lymphoma, Ann Arbor Stage IV Grade 3 Follicular Lymphoma, Ann Arbor Stage IV Marginal Zone Lymphoma, Composite Lymphoma, Indolent B-Cell Non-Hodgkin Lymphoma, Refractory Aggressive B-Cell Non-Hodgkin Lymphoma, Refractory Follicular Lymphoma, Refractory Grade 3b Follicular Lymphoma, Refractory High Grade B-Cell Lymphoma, Refractory Mantle Cell Lymphoma, Refractory Marginal Zone Lymphoma, Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma, Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma, Refractory Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma, Richter Syndrome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07480200: Effect of Trigger Point Cryostimulation on Exercise-Induced Tremor in Adolescent Swimmers

    Sponsor: Józef Piłsudski University of Physical Education. Phase: NA. Conditions: Physiological Tremor, Exercise-Induced Neuromuscular Fatigue

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07455292: Phenotyping Left Ventricle Failure With Hemodynamic Biomarkers From 4D Flow Magnetic Resonance Imaging

    Sponsor: IRCCS Policlinico S. Donato. Phase: NA. Conditions: Left Ventricle Function, Transcatheter Aortic Valve Replacement (TAVR), Aortic Valve Stenosis

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT04886492: CorEvitas SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions) Registry for Neuromyelitis Optica Spectrum Disorder (NMOSD)

    Sponsor: CorEvitas. Phase: . Conditions: Neuromyelitis Optica Spectrum Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07438236: Cognitive Performance and Mood After Ingestion of Dietary Supplement by University Students

    Sponsor: Cooperativa de Ensino Superior, Politécnico e Universitário. Phase: NA. Conditions: Cognitive Performance, Mood, Dietary Supplement, Safety

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04535011: PRACT to Investigate Controlling Alcohol Related Harms in a Low-Income Setting; Emergency Department BIs in Tanzania

    Sponsor: Duke University. Phase: NA. Conditions: Alcohol Use Disorder, Injury Traumatic, Trauma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05508971: Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)

    Sponsor: Oregon Health and Science University. Phase: NA. Conditions: Obstructive Sleep Apnea, Down Syndrome

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT05214092: Cortical Contributions to FFR: Post-Op Outcomes

    Sponsor: University of Pittsburgh. Phase: NA. Conditions: Language

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06991192: ACL Reconstruction Rehabilitation With Exercise and Psychological Support

    Sponsor: HealthPartners Institute. Phase: NA. Conditions: Anterior Cruciate Ligament Reconstruction Rehabilitation

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07416734: RCT of HeartBot in Women

    Sponsor: University of California, San Francisco. Phase: NA. Conditions: Participants Must be Women Aged 25 Years or Older, Participants Should Have no Self-reported History of Heart Disease or Stroke, Participants Should Have no Terminal Illness or Diagnosed Cognitive Impairment, Including Alzheimer's Disease, Participants Should Not be a Healthcare Professionals or Healthcare Trainees, Participants Should Not be Employed in the Healthcare Field, Participants Should Reside in the United States and be a University of California, San Francisco Health Patient, Participants Should Possess a Smartphone With an Active Data Plan or Access to Wi-Fi

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07220564: A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A

    Sponsor: Novo Nordisk A/S. Phase: PHASE1. Conditions: Haemophilia A

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07412509: Can 3D Modeling Enhance Patient Understanding, Education, and Surgical Outcomes in Gender Affirming Peritoneal Vaginoplasty?

    Sponsor: University of Chicago. Phase: . Conditions: Vaginoplasty, Gender Dysphoria, Adult

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07191509: Effects of Tracheostomy Decannulation on Respiratory Function

    Sponsor: Capital Medical University. Phase: . Conditions: Tracheostomy Decannulation

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04179864: A Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate Cancer

    Sponsor: Epizyme, Inc.. Phase: PHASE1. Conditions: Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06164951: A Study to Evaluate the Efficacy and Safety of Infigratinib in Children and Adolescents With Achondroplasia

    Sponsor: QED Therapeutics, a BridgeBio company. Phase: PHASE3. Conditions: Achondroplasia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07520929: Acute Sauna Session and Glucose Control

    Sponsor: University of Prince Edward Island. Phase: NA. Conditions: Obesity & Overweight

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05906602: Motor and Neurophysiological Changes After Ischemic Conditioning in Individuals With Stroke

    Sponsor: University of Illinois at Chicago. Phase: NA. Conditions: Stroke

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06385353: DVT Burden and the Risk of Post-thrombotic Syndrome

    Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer. Phase: NA. Conditions: Postthrombotic Syndrome

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06958731: In-plane Versus Real Time Bi-plane Single-operator Laser-assisted With a Innovative T-shaped Probe for Ultrasound-guided Internal Jugular Vein Catheterization:A Randomized Controlled Trial

    Sponsor: The First Hospital of Jilin University. Phase: NA. Conditions: Catheterization, Central Venous, Ultrasound Guided

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07426731: Comparison of Sacral ESP Block and Dorsal Penile Nerve Block in Pediatric Hypospadias Surgery

    Sponsor: Medipol University. Phase: NA. Conditions: Postoperative Pain, Hypospadias

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04591002: Osimertinib to Suppress the Progression of GGN(EGFR Mutation-positive)

    Sponsor: Samsung Medical Center. Phase: PHASE2. Conditions: Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06780202: Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients

    Sponsor: Emory University. Phase: PHASE2. Conditions: Foot Injuries and Disorders, Ankle Injuries and Disorders, Achilles Tendon Injury

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07414953: A Phase Ib Study of HS-10504 Combined Therapy in NSCLC

    Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Lung Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07318337: Effect of Drospirenone-Ethinyl Estradiol (20microgram vs 30 Microgram) on Free Androgen Index in PCOS

    Sponsor: Mst.Sumyara Khatun. Phase: NA. Conditions: PCOS (Polycystic Ovary Syndrome)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06089083: PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery

    Sponsor: University of California, San Francisco. Phase: . Conditions: Malignant Female Reproductive System Neoplasm, Gynecologic Cancer, Gynecologic Neoplasm

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04458883: The Next Leap in Cardiac Magnetic Resonance Imaging:Cycling the Field

    Sponsor: University of Aberdeen. Phase: NA. Conditions: Myocardial Infarction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07321041: Effect of Delivery Time on Umbilical Cord Blood Gas Parameters in Cesarean Sections Under General and Spinal Anesthesia

    Sponsor: Sisli Hamidiye Etfal Training and Research Hospital. Phase: . Conditions: Umbilical Cord Blood, Cesarean Section Surgery, General Anesthesia, Spinal Anesthesia, Blood Gas Analysis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05208905: LIFE-BTK PK Sub-study

    Sponsor: Abbott Medical Devices. Phase: NA. Conditions: Critical Limb Ischemia (CLI)

    full page →ctgov ↗
    ← prev
    page 20 of 98
    next →